GEN Poll Majority Favors Moratorium on Synthetic Bio Products
By GEN,
Genetic Engineering & Biotechnology News
| 04. 10. 2012
A majority of respondents to a recent GEN poll would like to see a moratorium on synthetic biotechnology products pending further regulations being put into place. 55.2% of respondents agreed with a group of 111 watchdog organizations including ETC Group and Friends of the Earth, which last month issued a report that called synthetic biology “an extreme form of genetic engineering” and asked for a moratorium on the release and commercial use of synthetic organisms and their products.While 3.9% of respondents were undecided about their position on this matter, 40.9%, did not feel the need for a moratorium.
Synthetic bio is among the latest examples of a scientific achievement that has generated as much fear among portions of the public as did DNA technology and stem cells. Over the years, however, those fears have been addressed by organizations assessing the risks and monitoring potential hazards of new biotechnologies.
Related Articles
By Vuyile Madwantsi, Independent Online | 08.22.2025
Imagine this: a future where parents could choose their baby’s eye colour, height or even intelligence.
Sounds like science fiction, right? But it’s closer than you think.
Let’s start with a simple, human truth: most of us want healthy children...
By Jacob Bogage, The Washington Post | 09.03.2025
The conservative group behind the Project 2025 governing playbook for President Donald Trump’s second term is set to propose sweeping revisions to U.S. economic policy meant to encourage married heterosexual couples to have more children.
The Heritage Foundation, a right-wing...
By Harry Hunter, PET BioNews | 08.11.2025
The Parliamentary Office of Science and Technology has announced plans to publish a POSTnote and called for submissions on surrogacy law in the UK and internationally.
The current UK surrogacy laws, largely based on legislation from the 1980s, have been...
By Gregory Laub and Hannah Glaser, MedPage Today | 08.07.2025
In this MedPage Today interview, Leigh Turner, PhD, a professor of health policy and bioethics at the University of California Irvine, unpacks the growing influence of stem cell clinics and the blurred line between medicine and marketing. He explains how...